Stem Cells Grown in Osteogenic Medium on PLGA, PLGA/HA, and Titanium Scaffolds for Surgical Applications

被引:37
作者
Asti, Annalia [1 ,2 ]
Gastaldi, Giulia [2 ,3 ]
Dorati, Rossella [4 ]
Saino, Enrica [2 ,5 ]
Conti, Bice [2 ,4 ]
Visai, Livia [2 ,5 ]
Benazzo, Francesco [1 ,2 ]
机构
[1] Univ Pavia, San Matteo Hosp Inst, SMEC Dept, IRCCS Fdn,Orthopaed & Traumatol Dept, I-27100 Pavia, Italy
[2] Univ Pavia, CIT, I-27100 Pavia, Italy
[3] Univ Pavia, Sect Human Physiol, Dept Physiol, I-27100 Pavia, Italy
[4] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy
[5] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy
关键词
IN-VITRO; INTERNATIONAL-SOCIETY; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; TISSUE; DIFFERENTIATION; EXPRESSION; BEHAVIOR; TI6AL4V; PLASMA;
D O I
10.1155/2010/831031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pluripotent adipose tissue-derived stem cells (hASCs) can differentiate into various mesodermal cell types such as osteoblasts, chondroblasts, and myoblasts. We isolated hASCs from subcutaneous adipose tissue during orthopaedic surgery and induced the osteogenic differentiation for 28 days on three different synthetic scaffolds such as polylactide-co-glycolide (PLGA), polylactide-co-glycolide/hydroxyapatite (PLGA/HA), and trabecular titanium scaffolds (Ti6Al4V). Pore size can influence certain criteria such as cell attachment, infiltration, and vascularization. The aim of this study was to investigate the performance of PLGA and PLGA/HA scaffolds with a higher porosity, ranging between 75% and 84%, with respect to Ti scaffolds but with smaller pore size, seeded with hASCs to develop a model that could be used in the treatment of bone defects and fractures. Osteogenesis was assessed by ELISA quantitation of extracellular matrix protein expression, von Kossa staining, X-ray microanalysis, and scanning electron microscopy. The higher amount of protein matrix on the Ti scaffold with respect to PLGA and PLGA/HA leads to the conclusion that not only the type of material but the structure significantly affects cell proliferation.
引用
收藏
页数:12
相关论文
共 47 条
  • [1] [Anonymous], 1988, Antibodies: A laboratory manual
  • [2] Asti Annalia, 2008, Technol Health Care, V16, P401
  • [3] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [4] Biomaterial developments for bone tissue engineering
    Burg, KJL
    Porter, S
    Kellam, JF
    [J]. BIOMATERIALS, 2000, 21 (23) : 2347 - 2359
  • [5] Synthetic bone scaffolds and fracture repair
    Carson, Joshua S.
    Bostrom, Mathias P. G.
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2007, 38 : S33 - S37
  • [6] Poly(D,L-lactic acid) coated 45S5 Bioglass®-based scaffolds:: Processing and characterization
    Chen, Q. Z.
    Boccaccini, A. R.
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 77A (03) : 445 - 457
  • [7] Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering
    Chung, Hyun Jung
    Park, Tae Gwan
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (4-5) : 249 - 262
  • [8] Doi K, 1996, J BIOMED MATER RES, V31, P27, DOI 10.1002/(SICI)1097-4636(199605)31:1<27::AID-JBM4>3.0.CO
  • [9] 2-S
  • [10] Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    Dominici, M.
    Le Blanc, K.
    Mueller, I.
    Slaper-Cortenbach, I.
    Marini, F. C.
    Krause, D. S.
    Deans, R. J.
    Keating, A.
    Prockop, D. J.
    Horwitz, E. M.
    [J]. CYTOTHERAPY, 2006, 8 (04) : 315 - 317